• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580].

作者信息

Fradera Xavier, Methot Joey L, Achab Abdelghani, Christopher Matthew, Altman Michael D, Zhou Hua, McGowan Meredeth A, Kattar Sam D, Wilson Kevin, Garcia Yudith, Augustin Martin A, Lesburg Charles A, Shah Sanjiv, Goldenblatt Peter, Katz Jason D

机构信息

Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA.

Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA.

出版信息

Bioorg Med Chem Lett. 2020 Aug 15;30(16):127363. doi: 10.1016/j.bmcl.2020.127363. Epub 2020 Jun 23.

DOI:10.1016/j.bmcl.2020.127363
PMID:32591133
Abstract
摘要

相似文献

1
Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580].
Bioorg Med Chem Lett. 2020 Aug 15;30(16):127363. doi: 10.1016/j.bmcl.2020.127363. Epub 2020 Jun 23.
2
Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066].
Bioorg Med Chem Lett. 2017 May 1;27(9):2079. doi: 10.1016/j.bmcl.2017.03.046. Epub 2017 Mar 24.
3
Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow.采用迭代骨架跃迁工作流程设计选择性 PI3Kδ 抑制剂。
Bioorg Med Chem Lett. 2019 Sep 15;29(18):2575-2580. doi: 10.1016/j.bmcl.2019.08.004. Epub 2019 Aug 5.
4
Corrigendum to 'Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors' [Bioorg. Med. Chem. Lett. 29 (2019) 126675].
Bioorg Med Chem Lett. 2020 Jan 15;30(2):126771. doi: 10.1016/j.bmcl.2019.126771. Epub 2019 Dec 16.
5
Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].
Bioorg Med Chem Lett. 2019 Sep 1;29(17):2525. doi: 10.1016/j.bmcl.2019.07.032. Epub 2019 Jul 25.
6
Corrigendum to "Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors" [Bioorg. Med. Chem. Lett. 30 (2020) 127551].
Bioorg Med Chem Lett. 2021 Oct 1;49:128262. doi: 10.1016/j.bmcl.2021.128262. Epub 2021 Aug 2.
7
Corrigendum to "Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research" [Bioorg. Med. Chem. Lett. 29 (2019) 2016-2024].
Bioorg Med Chem Lett. 2021 Aug 1;45:128140. doi: 10.1016/j.bmcl.2021.128140. Epub 2021 May 27.
8
Corrigendum to "Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors" [Bioorg. Med. Chem. Lett. 60 (2022) 128549].
Bioorg Med Chem Lett. 2022 Sep 15;72:128856. doi: 10.1016/j.bmcl.2022.128856. Epub 2022 Jun 18.
9
Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".《新型噻二唑 - 噻唑啉酮杂化物作为人有丝分裂驱动蛋白Eg5潜在抑制剂的设计与合成》勘误 [《生物有机与药物化学快报》28 (17) (2018) 2930 - 2938]
Bioorg Med Chem Lett. 2018 Nov 15;28(21):3489. doi: 10.1016/j.bmcl.2018.08.029. Epub 2018 Sep 29.
10
Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].《作为TRK抑制剂的大环衍生物的设计、合成及生物学评价》的勘误[《生物有机与药物化学快报》53 (2021) 128409]
Bioorg Med Chem Lett. 2022 Jan 15;56:128502. doi: 10.1016/j.bmcl.2021.128502. Epub 2021 Dec 11.